News

The latest press releases, articles, and events for Innoviva Specialty Therapeutics.

Filter by:

All News Press Releases Events

06.03.2023

Clinical Outcomes of Eravacycline in Patients Treated Predominately for Carbapenem-Resistant Acinetobacter baumannii

Read More

06.03.2023

In vitro activity of eravacycline and comparator agents against bacterial pathogens isolated from patients with cancer

Read More

04.26.2022

IN VITRO SURVEILLANCE OF ERAVACYCLINE AGAINST GRAM-POSITIVE PATHOGENS, INCLUDING RESISTANT ISOLATES, COLLECTED WORLDWIDE DURING 2020

Read More

04.26.2022

Assessing the Real-world Clinical Outcomes of Patients Treated with Eravacycline for Complicated Intra-abdominal Infections

Read More

11.14.2021

A retrospective, multicentre evaluation of eravacycline utilisation in community and academic hospitals

Read More

10.03.2021

Evaluation of Predictors of Clinical Success in Patients Treated with Eravacycline for Various Infections

Read More

10.03.2021

In Vitro Activity of Eravacycline Against Clinically Significant Bacteria Isolated from Patients with Cancer

Read More

07.15.2021

Eravacycline pharmacokinetics in a critically ill patient receiving venovenous extracorporeal membrane oxygenation and continuous venovenous haemodialysis

Read More

11.17.2020

Efficacy and Tolerability of Eravacycline in Bacteremic Patients with Complicated Intra-Abdominal Infection: A Pooled Analysis from the IGNITE1 and IGNITE4 Studies

Read More

11.13.2020

Efficacy and Safety of Eravacycline in Obese Patients: A Post Hoc Analysis of Pooled Data From the IGNITE1 and IGNITE4 Clinical Trials

Read More